Hospital de la Santa Creu i Sant Paul

Barcelona 08041

0 studies enrolling now · 5 studies all time

What they study most

Acute Myeloid Leukemia, Anaplastic Large-Cell Lymphoma, Disease, Hodgkin, Lymphoma, B-cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large B-cell, Diffuse, Lymphoma, Non-Hodgkin, Non-Hodgkin Lymphoma, T-Cell Lymphoma

Studies at this site

• ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas — Completed
• A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial) — Completed
• Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia — Stopped early
• Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL) — Stopped early
• A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL — Stopped early